Tobit Laboratories AG TeamDavid's Webbox application is vulnerable to HTTP header injection through the “cType” URL
Source GCVE Database
Not known to be exploited · CVSS 5.3 Medium : upgrade to Rollout 528 when convenient.
Data as of 5 Nov 2026, 23:24 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 39% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in Rollout 528
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 7 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 5 Nov 2026.
What to do
Upgrade TeamDavid to Rollout 528.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Tobit Laboratories AGTeamDavid | Affected
| Fixed in
|
AI-suggested
If you cannot patch yet, users should consider restricting or sanitizing the “cType” URL parameter input to prevent injection of control characters.
Description
Tobit Laboratories AG TeamDavid's Webbox application has a vulnerability in the “cType” URL parameter that allows HTTP header injection. This flaw permits attackers to inject arbitrary headers, including additional Location headers, by exploiting improper filtering of control characters such as URL-encoded newlines. This can lead to open redirect vulnerabilities. The issue affects TeamDavid through Rollout 524.